BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34001794)

  • 1. Ovarian Mucinous Carcinoma in a Pediatric Patient With Maroteaux-Lamy Syndrome.
    Yazal Erdem A; Özyörük D
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1128-e1131. PubMed ID: 34001794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Insights into Mucinous Ovarian Carcinoma.
    Ricci F; Affatato R; Carrassa L; Damia G
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29795040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different etiologies of mucinous and nonmucinous epithelial ovarian cancers.
    Purdie DM; Webb PM; Siskind V; Bain CJ; Green AC
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S145-8. PubMed ID: 12586107
    [No Abstract]   [Full Text] [Related]  

  • 4. New Insight into Mucinous Ovarian Cancer.
    Cancer Discov; 2015 Sep; 5(9):900. PubMed ID: 26156090
    [No Abstract]   [Full Text] [Related]  

  • 5. Mental retardation in a patient with Maroteaux-Lamy.
    Vestermark S; Tønnesen T; Andersen MS; Güttler F
    Clin Genet; 1987 Feb; 31(2):114-7. PubMed ID: 3103957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearing of cornea after perforating keratoplasty in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).
    Naumann G
    N Engl J Med; 1985 Apr; 312(15):995. PubMed ID: 3919302
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral and systemic manifestations of mucopolysaccharidosis type VI: a report of seven cases.
    de Almeida-Barros RQ; Oka SC; Pordeus AC; de Medeiros PF; Bento PM; Godoy GP
    Quintessence Int; 2012 Mar; 43(3):e32-8. PubMed ID: 22299127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) in the pre-Columbian culture of Colombia.
    Pachajoa H; Rodriguez CA
    Colomb Med (Cali); 2014; 45(2):85-7. PubMed ID: 25100895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).
    Wald SL; Schmidek HH
    Neurosurgery; 1984 Jan; 14(1):83-8. PubMed ID: 6420724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.
    Brooks DA; Gibson GJ; Karageorgos L; Hein LK; Robertson EF; Hopwood JJ
    Mol Genet Metab; 2005 Jul; 85(3):236-8. PubMed ID: 15979036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maroteaux-Lamy syndrome.
    Lakhotia S; Sharma A; Shrivastava GP; Jain SK
    Indian J Pediatr; 2004 Oct; 71(10):933-5. PubMed ID: 15531839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of oral manifestations of patients with mucopolysaccharidosis IV and VI: clinical and imaging study.
    de Almeida-Barros RQ; de Medeiros PFV; de Almeida Azevedo MQ; de Oliveira Lira Ortega A; Yamamoto ATA; Dornelas SKL; Bento PM
    Clin Oral Investig; 2018 Jan; 22(1):201-208. PubMed ID: 28315965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).
    Golda A; Jurecka A; Tylki-Szymanska A
    Int J Cardiol; 2012 Jun; 158(1):6-11. PubMed ID: 21737154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maroteaux-Lamy syndrome: orofacial features after treatment by bone marrow transplant.
    Guimarães Mdo C; de Farias SM; Costa AM; de Amorim RF
    Oral Health Prev Dent; 2010; 8(2):139-42. PubMed ID: 20589247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cigarette smoking with the risk of ovarian cancer.
    Pan SY; Ugnat AM; Mao Y; Wen SW; Johnson KC;
    Int J Cancer; 2004 Aug; 111(1):124-30. PubMed ID: 15185353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case.
    Tamaki N; Kojima N; Tanimoto M; Suyama T; Matsumoto S
    Neurosurgery; 1987 Sep; 21(3):416-9. PubMed ID: 3118237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose.
    Lachman RS; Burton BK; Clarke LA; Hoffinger S; Ikegawa S; Jin DK; Kano H; Kim OH; Lampe C; Mendelsohn NJ; Shediac R; Tanpaiboon P; White KK
    Skeletal Radiol; 2014 Mar; 43(3):359-69. PubMed ID: 24389823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors in ovarian cancer of epithelial origin by pathological diagnosis.
    Koch M
    Br J Cancer; 1989 Feb; 59(2):257-8. PubMed ID: 2539175
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophage involvement in mitral valve pathology in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).
    Brands M; Roelants J; de Krijger R; Bogers A; Reuser A; van der Ploeg A; Helbing W
    Am J Med Genet A; 2013 Oct; 161A(10):2550-3. PubMed ID: 23949968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.